CARYHEALTH
Live / Registered — Registered (as of 04 Mar 2025)
What this means for you
Registered since 04 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98215759
- Registration number
- 7717034
- Mark type
- Stylized text
- Filed
- 09 Oct 2023
- Published for opposition
- 11 Jun 2024
- Registered
- 04 Mar 2025
Goods and services
- Class 035 — Advertising and business services: Mail order pharmacy services; retail pharmacy services; specialized retail pharmacy services for patients with particular medical conditions
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software using artificial intelligence for the provision of clinical drug information and recommendations; software as a service (SAAS) services featuring software using artificial intelligence for analysis of patient data; software as a service (SAAS) services featuring software using artificial intelligence for population health management; application service provider featuring application programming interface (API) software for healthcare
Owner
- Cary Rx Inc., Washington, DC, US
- Cary Rx Inc., Washington, DC, US
- Cary Rx Inc., Washington, DC, US
Prior registrations
Prosecution history
- 04 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Feb 2025 — EXAMINER'S AMENDMENT ENTERED
- 10 Feb 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2025 — EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2025 — SU-EXAMINER'S AMENDMENT WRITTEN
- 23 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Oct 2024 — NON-FINAL ACTION E-MAILED
- 23 Oct 2024 — SU - NON-FINAL ACTION - WRITTEN
- 22 Oct 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Aug 2024 — USE AMENDMENT FILED
- 18 Oct 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Aug 2024 — TEAS STATEMENT OF USE RECEIVED